Leaders of the American Society of Health-System Pharmacists (ASHP) say the time is now to prepare for providing innovative ...

Gene therapy with voretigene neparvovec-rzyl partially ... the patients' RT pathway remained strengthened even after the retinal intervention." "These findings not only provide useful ...

Aaron Nagiel treats the first patient at CHLA with Luxturna retinal gene therapy in 2017. In 2024, Dr. Nagiel's team celebrated its 100th Luxturna procedure. (Photo: Business Wire) There’s no ...

It is focusing on retinal diseases, with its most advanced ... to legal blindness when they reach their early forties. The gene therapy was acquired from US biotech AGTC in 2022 by Syncona ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

A national leader in pediatric gene therapy, CHLA has treated more patients with the sight-saving Luxturna than any other ...

Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for inherited retinal ...

Proliferative vitreoretinopathy (PVR) is an eye condition that leads to blindness and can currently only be addressed with ...

A Durham biotechnology firm is partnering with a Japanese company to advance a gene therapy that has shown promise in ...